Loading clinical trials...
Loading clinical trials...
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial to Explore the Safety, Tolerability, Pharmacokinetics, and Efficacy of PRAX-114 in the Treatment of Adults With Essential Tremor
Conditions
Interventions
10 mg PRAX-114, 20 mg PRAX-114, and Placebo
10 mg PRAX-114 or 20 mg PRAX-114
Locations
3
United States
Praxis Research Site
Boca Raton, Florida, United States
Praxis Research Site
Farmington Hills, Michigan, United States
Praxis Research Site
Kirkland, Washington, United States
Start Date
April 5, 2022
Primary Completion Date
June 30, 2022
Completion Date
June 30, 2022
Last Updated
November 30, 2022
NCT07417280
NCT04212780
NCT03984643
NCT01581580
NCT07056361
NCT01734122
Lead Sponsor
Praxis Precision Medicines
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions